BD MAX
Total Payments
$8.3M
Transactions
1,857
Doctors
1,247
Companies
6
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $2.4M | 546 | 412 |
| 2021 | $702,628 | 520 | 421 |
| 2020 | $447,016 | 374 | 286 |
| 2019 | $286,645 | 221 | 183 |
| 2018 | $1.8M | 94 | 46 |
| 2017 | $2.7M | 102 | 57 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.7M | 107 | 92.6% |
| Royalty or License | $370,554 | 12 | 4.4% |
| Gift | $76,692 | 9 | 0.9% |
| Food and Beverage | $63,638 | 1,674 | 0.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $53,375 | 2 | 0.6% |
| Charitable Contribution | $27,929 | 25 | 0.3% |
| Travel and Lodging | $22,333 | 22 | 0.3% |
| Education | $4,948 | 6 | 0.1% |
Payments by Type
Research
$7.7M
107 transactions
General
$619,469
1,750 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| MAXMM1 | Becton, Dickinson and Company | $2.2M | 0 |
| Clinical Evaluation of the BD MAX STI Plus Assay, when performed on the BD MAX System | Becton, Dickinson and Company | $1.7M | 0 |
| MAX MTB Clinical | Becton, Dickinson and Company | $1.4M | 0 |
| Covid BioSpec | Becton, Dickinson and Company | $687,434 | 0 |
| MCTGCTV2 BD MAX | Becton, Dickinson and Company | $209,940 | 0 |
| BDS-MVPTV2Rem | Becton, Dickinson and Company | $205,973 | 0 |
| MAX CTGCTV1 | Becton, Dickinson and Company | $192,738 | 0 |
| Comparison of BD MAX Vaginal Panel and BD Affirm VPIII | Becton, Dickinson and Company | $128,908 | 0 |
| Molecular-Based BD MAX Extended Enteric Bacterial Panel and of the BD MAX Enteric Viral Panel for the Detection of Enteric Pathogens from Unpreserved and Cary-Blair Preserved Stool Specimens | Becton, Dickinson and Company | $92,259 | 0 |
| MAX Extended Enteric | Becton, Dickinson and Company | $89,355 | 0 |
| Intraluminal Central Catheter Related Thrombotic Occlusion and Infection; Is there a Relationship to Mechanical Valve Needleless Connector Design | Becton, Dickinson and Company | $89,153 | 0 |
| MCTGCTV2 BD MAX Enteric Bacterial Panel | Becton, Dickinson and Company | $82,663 | 0 |
| MAX MTB Pre-Clin | Becton, Dickinson and Company | $78,826 | 0 |
| Compatibility of FecalSwab in combination with BD MAX EBP | Becton, Dickinson and Company | $74,010 | 0 |
| C-FORWARD | Becton, Dickinson and Company | $64,405 | 0 |
| HT HPV Onclarity - Request C08 BioSpec | Becton, Dickinson and Company | $54,000 | 0 |
| NorthShore Study | Becton, Dickinson and Company | $45,174 | 0 |
| MAX MTB CLINICAL | BECTON, DICKINSON AND COMPANY | $43,355 | 0 |
| MCTGCTV2 BD MAX | BECTON, DICKINSON AND COMPANY | $37,117 | 0 |
| Evaluation with the BD MAX Enteric Parasite Panel with stool samples in Total-Fix and Cary-Blair medium | Becton, Dickinson and Company | $33,210 | 0 |
Top Doctors Receiving Payments for BD MAX — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Surgery | Jackson, MS | $171.61 | 2 |
| , M.D | Surgery | Jackson, MS | $171.61 | 2 |
| , M.D | Surgery | Danville, KY | $168.32 | 4 |
| , MD | Surgery | San Antonio, TX | $167.29 | 7 |
| , MD | Surgery | Chicago, IL | $166.51 | 3 |
| , M.D | Surgery | Saint Louis, MO | $163.87 | 1 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Red Bank, NJ | $163.38 | 3 |
| Vincent Caldarola | — | San Antonio, TX | $162.46 | 2 |
| , MD | Surgery | Shrewsbury, NJ | $162.23 | 2 |
| , M.D | Surgery | Detroit, MI | $159.68 | 1 |
| , M.D | Surgery | Anchorage, AK | $158.68 | 4 |
| , MD | Colon & Rectal Surgery | Oakhurst, NJ | $158.11 | 1 |
| , MD FACS | Surgery | Shrewsbury, NJ | $154.66 | 2 |
| , DO | Specialist | Porterville, CA | $151.57 | 3 |
| , PA-C | Medical | Phoenix, AZ | $149.18 | 1 |
| , MD | Surgery | Round Rock, TX | $148.99 | 1 |
| , MD | Surgery | Omaha, NE | $146.37 | 8 |
| , M.D | Specialist | Plainsboro, NJ | $144.55 | 4 |
| , M.D | Surgery | Lexington, KY | $143.72 | 3 |
| , M.D | Surgery | Danville, IN | $143.40 | 1 |
| , M.D | Surgery | Boca Raton, FL | $139.89 | 2 |
| , M.D | Surgery | Louisville, KY | $139.71 | 2 |
| , M.D | Specialist | Houston, TX | $138.92 | 4 |
| , MD | Specialist | Joliet, IL | $134.16 | 1 |
| , M.D | Surgery | Joliet, IL | $134.15 | 1 |
Ad
Manufacturing Companies
- Becton, Dickinson and Company $8.2M
- BECTON, DICKINSON AND COMPANY $104,502
- Davol Inc. $50,456
- DAVOL INC. $9,943
- Bard Peripheral Vascular, Inc. $162.41
- C. R. Bard, Inc. & Subsidiaries $32.12
Product Information
- Type Device
- Total Payments $8.3M
- Total Doctors 1,247
- Transactions 1,857
About BD MAX
BD MAX is a device associated with $8.3M in payments to 1,247 healthcare providers, recorded across 1,857 transactions in the CMS Open Payments database. The primary manufacturer is Becton, Dickinson and Company.
Payment data is available from 2017 to 2022. In 2022, $2.4M was paid across 546 transactions to 412 doctors.
The most common payment nature for BD MAX is "Unspecified" ($7.7M, 92.6% of total).
BD MAX is associated with 20 research studies, including "MAXMM1" ($2.2M).